{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T17:08:11Z","timestamp":1744650491345},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,7]]},"DOI":"10.7759\/cureus.34714","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T10:36:38Z","timestamp":1675766198000},"source":"Crossref","is-referenced-by-count":3,"title":["Polymyalgia Rheumatica (PMR) Lacking Shoulder Pain Following COVID-19 Vaccination"],"prefix":"10.7759","author":[{"given":"Kotaro","family":"Haruna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Shirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10155","article-title":"Polymyalgia rheumatica and giant cell arteritis","volume":"324","author":"Buttgereit F","year":"2020","unstructured":"Buttgereit F, Matteson EL, Dejaco C. Polymyalgia rheumatica and giant cell arteritis. JAMA. 2020, 324:993-994. 10.1001\/jama.2020.10155","journal-title":"JAMA"},{"key":"ref2","unstructured":"Johns Hopkins University and Medicine Coronavirus Resource Center. (2023). Accessed. January 21, 2023: https:\/\/coronavirus.jhu.edu."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga WJ","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020, 324:782-793. 10.1001\/jama.2020.12839","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad A","year":"2021","unstructured":"Watad A, De Marco G, Mahajna H, et al.. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination. Vaccines (Basel). 2021, 9:435. 10.3390\/vaccines9050435","journal-title":"Vaccines (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-5-672","article-title":"Polymyalgia rheumatica: a 10-year epidemiologic and clinical study","volume":"97","author":"Chuang TY","year":"1982","unstructured":"Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med. 1982, 97:672-680. 10.7326\/0003-4819-97-5-672","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(84)90012-x","article-title":"Long-term follow-up of polymyalgia rheumatica: evidence for synovitis","volume":"13","author":"Healey LA","year":"1984","unstructured":"Healey LA. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum. 1984, 13:322-328. 10.1016\/0049-0172(84)90012-x","journal-title":"Semin Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105334","article-title":"Polymyalgia rheumatica following COVID-19 vaccination: a case-series of ten patients","volume":"89","author":"Ottaviani S","year":"2022","unstructured":"Ottaviani S, Juge PA, Forien M, Ebstein E, Palazzo E, Dieud\u00e9 P. Polymyalgia rheumatica following COVID-19 vaccination: a case-series of ten patients. Joint Bone Spine. 2022, 89:105334. 10.1016\/j.jbspin.2021.105334","journal-title":"Joint Bone Spine"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5114\/reum.2022.115665","article-title":"Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literature","volume":"60","author":"Manzo C","year":"2022","unstructured":"Manzo C, Castagna A, Isetta M. Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literature. Reumatologia. 2022, 60:142-147. 10.5114\/reum.2022.115665","journal-title":"Reumatologia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8651-21","article-title":"New-onset polymyalgia rheumatica following the administration of the Pfizer-BioNTech COVID-19 vaccine","volume":"61","author":"Osada A","year":"2022","unstructured":"Osada A, Sakuragi C, Toya C, Mitsuo A. New-onset polymyalgia rheumatica following the administration of the Pfizer-BioNTech COVID-19 vaccine. Intern Med. 2022, 61:749-753. 10.2169\/internalmedicine.8651-21","journal-title":"Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330314","article-title":"Atypical presentations of polymyalgia rheumatica","volume":"33","author":"Fitzcharles MA","year":"1990","unstructured":"Fitzcharles MA, Esdaile JM. Atypical presentations of polymyalgia rheumatica. Arthritis Rheum. 1990, 33:403-406. 10.1002\/art.1780330314","journal-title":"Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine1962.28.452","article-title":"Clinical studies of polymyalgia rheumatica. A proposal of diagnostic criteria","volume":"28","author":"Nobunaga M","year":"1989","unstructured":"Nobunaga M, Yoshioka K, Yasuda M, Shingu M. Clinical studies of polymyalgia rheumatica. A proposal of diagnostic criteria. Jpn J Med. 1989, 28:452-456. 10.2169\/internalmedicine1962.28.452","journal-title":"Jpn J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew202","article-title":"Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: a controlled study","volume":"55","author":"Sondag M","year":"2016","unstructured":"Sondag M, Guillot X, Verhoeven F, Blagosklonov O, Prati C, Boulahdour H, Wendling D. Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: a controlled study. Rheumatology (Oxford). 2016, 55:1452-1457. 10.1093\/rheumatology\/kew202","journal-title":"Rheumatology (Oxford)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-05162-6","article-title":"Diagnostic value of [18F]FDG-PET\/CT in polymyalgia rheumatica: a systematic review and meta-analysis","volume":"48","author":"van der Geest KS","year":"2021","unstructured":"van der Geest KS, Treglia G, Glaudemans AW, Brouwer E, Jamar F, Slart RH, Gheysens O. Diagnostic value of [18F]FDG-PET\/CT in polymyalgia rheumatica: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2021, 48:1876-1889. 10.1007\/s00259-020-05162-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.140194","article-title":"Expression and function of toll-like receptors in peripheral blood mononuclear cells of patients with polymyalgia rheumatica and giant cell arteritis","volume":"70","author":"\u00c1lvarez Rodr\u00edguez L","year":"2011","unstructured":"\u00c1lvarez Rodr\u00edguez L, L\u00f3pez-Hoyos M, Mata C, et al.. Expression and function of toll-like receptors in peripheral blood mononuclear cells of patients with polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis. 2011, 70:1677-1683. 10.1136\/ard.2010.140194","journal-title":"Ann Rheum Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03791-x","article-title":"Systems vaccinology of the BNT162b2 mRNA vaccine in humans","volume":"596","author":"Arunachalam PS","year":"2021","unstructured":"Arunachalam PS, Scott MK, Hagan T, et al.. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature. 2021, 596:410-416. 10.1038\/s41586-021-03791-x","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13874","article-title":"Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer\/BioNTech mRNA COVID-19 vaccine","volume":"51","author":"Sellaturay P","year":"2021","unstructured":"Sellaturay P, Nasser S, Islam S, Gurugama P, Ewan PW. Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer\/BioNTech mRNA COVID-19 vaccine. Clin Exp Allergy. 2021, 51:861-863. 10.1111\/cea.13874","journal-title":"Clin Exp Allergy"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/131866-polymyalgia-rheumatica-pmr-lacking-shoulder-pain-following-covid-19-vaccination","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:13Z","timestamp":1707508753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/131866-polymyalgia-rheumatica-pmr-lacking-shoulder-pain-following-covid-19-vaccination"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.34714","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,7]]}}}